Latest eBooks

Cell-based assays offer extensive advantages across multiple fields of research, advantages that can be maximised by the specialised features and high throughput capabilities of microplate readers.

In the “Quality by Design” approach for monoclonal antibody (mAb)-based therapeutics development, stability characterization—the probability of a protein unfolding—is performed to ensure that structure and function are preserved throughout development and manufacturing.

Download this eBook to discover how advances in different technologies and techniques continue to expand the possibilities of personalized medicine.

Download this eBook to explore recent advances in proteomics technologies, key applications including vaccine design and drug development, and the problem of understudied proteins.

Artificial intelligence (AI) is changing the game for drug discovery and repurposing. There are currently more than 100 drugs in the AI drug discovery pipeline and numerous more that are making their way to clinical trials in a matter of years—instead of decades.

While CRISPR-edited cell lines can be beneficial for target identification, reagent validation, and biomarker discovery, generating high-quality cell lines can be fraught with difficulties and time-consuming and relies on several factors.

Flow cytometry allows for unparalleled multiplexing, while providing the flexibility, speed and reproducibility to analyze a high number of individual events and determine their distributions.

Dynamic light scattering (DLS) is a way of measuring particle size, oligomerization, dispersity — and how they change in response to environmental changes like the addition of a drug conjugate or storage buffer modifications.

Download this eBook to learn how advances in mass spectrometry techniques in combination with cryo-electron microscopy and other structural tools is revolutionizing the understanding of protein structure, function and dynamics.

Download this eBook to learn more about finding proteins that cause disease, how proteomics enriches the multiomic study of disease as well as the future of proteomics in multiomics research.